WCLC 2025 - Posters & ePosters-EP.06.83 Prognostic Impact of PD-L1 Expression in a Swiss Cohort ofEGFR-Mutant Non-Small Cell Lung Cancer Patients Treated With First-Line Osimertinib

EP.06.83 Prognostic Impact of PD-L1 Expression in a Swiss Cohort ofEGFR-Mutant Non-Small Cell Lung Cancer Patients Treated With First-Line Osimertinib

Back to course

Asset Subtitle

Alexandra Schuler

Meta Tag

Speaker Alexandra Schuler

Topic Pathology and Biomarkers